Home - Products - MAPK/ERK Signaling - p38 MAPK - methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate

CAS No. 517870-17-6

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate( —— )

Catalog No. M24490 CAS No. 517870-17-6

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	45	In Stock
10MG	68	In Stock
25MG	115	In Stock
50MG	173	In Stock
100MG	258	In Stock
200MG	388	In Stock
500MG	642	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate
Note

Research use only, not for human use.
Brief Description

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.
Description

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

p38 MAPK
Recptor

MAPK
Research Area

——
Indication

——

Chemical Information

CAS Number

517870-17-6
Formula Weight

263.25
Molecular Formula

C13H13NO5
Purity

>98% (HPLC)
Solubility

DMSO:10 mM
SMILES

COC1=C(C=C(C=C1)C2=CC(=NO2)C(=O)OC)OC
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

16,17-Epoxypregnenol

16,17-Epoxypregnenol
Losmapimod

Losmapimod (GSK-AHAB, GW856553X, SB856553)?is a selective, potent, orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively.
Ro-3201195

Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.

Sign In Join Free